PINK1 signaling in mitochondrial homeostasis and in aging (Review)
- Authors:
- Yasuko Kitagishi
- Noriko Nakano
- Mako Ogino
- Mayuko Ichimura
- Akari Minami
- Satoru Matsuda
-
Affiliations: Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya, Nishimachi, Nara 630-8506, Japan - Published online on: December 12, 2016 https://doi.org/10.3892/ijmm.2016.2827
- Pages: 3-8
This article is mentioned in:
Abstract
Prasad AS: Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging. J Trace Elem Med Biol. 28:364–371. 2014. View Article : Google Scholar : PubMed/NCBI | |
Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT and Hayes JD: Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 88:108–146. 2015. View Article : Google Scholar : PubMed/NCBI | |
Campbell GR, Worrall JT and Mahad DJ: The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler. 20:1806–1813. 2014. View Article : Google Scholar : PubMed/NCBI | |
Erpapazoglou Z and Corti O: The endoplasmic reticulum/mitochondria interface: A subcellular platform for the orchestration of the functions of the PINK1-Parkin pathway? Biochem Soc Trans. 43:297–301. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kaminsky YG, Tikhonova LA and Kosenko EA: Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria. Front Biosci (Landmark Ed). 20:173–197. 2015. View Article : Google Scholar | |
Oyewole AO and Birch-Machin MA: Mitochondria-targeted antioxidants. FASEB J. 29:4766–4771. 2015. View Article : Google Scholar : PubMed/NCBI | |
Tocchi A, Quarles EK, Basisty N, Gitari L and Rabinovitch PS: Mitochondrial dysfunction in cardiac aging. Biochim Biophys Acta. 1847:1424–1433. 2015. View Article : Google Scholar : PubMed/NCBI | |
Pan Y, Nishida Y, Wang M and Verdin E: Metabolic regulation, mitochondria and the life-prolonging effect of rapamycin: A mini-review. Gerontology. 58:524–530. 2012. View Article : Google Scholar : PubMed/NCBI | |
Quirós PM, Langer T and López-Otín C: New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol. 16:345–359. 2015. View Article : Google Scholar : PubMed/NCBI | |
Durcan TM and Fon EA: The three ‘P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 29:989–999. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wilhelmus MM, van der Pol SM, Jansen Q, Witte ME, van der Valk P, Rozemuller AJ, Drukarch B, de Vries HE and Van Horssen J: Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions. Free Radic Biol Med. 50:469–476. 2011. View Article : Google Scholar | |
Russell AP, Foletta VC, Snow RJ and Wadley GD: Skeletal muscle mitochondria: A major player in exercise, health and disease. Biochim Biophys Acta. 1840:1276–1284. 2014. View Article : Google Scholar | |
Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP and Youle RJ: Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol. 191:933–942. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sekine S, Kanamaru Y, Koike M, Nishihara A, Okada M, Kinoshita H, Kamiyama M, Maruyama J, Uchiyama Y, Ishihara N, et al: Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J Biol Chem. 287:34635–34645. 2012. View Article : Google Scholar : PubMed/NCBI | |
Shi G, Lee JR, Grimes DA, Racacho L, Ye D, Yang H, Ross OA, Farrer M, McQuibban GA and Bulman DE: Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum Mol Genet. 20:1966–1974. 2011. View Article : Google Scholar : PubMed/NCBI | |
Pickrell AM and Youle RJ: The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. 85:257–273. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI and Youle RJ: The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 524:309–314. 2015. View Article : Google Scholar : PubMed/NCBI | |
Weihofen A, Ostaszewski B, Minami Y and Selkoe DJ: Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet. 17:602–616. 2008. View Article : Google Scholar | |
d'Amora M, Angelini C, Marcoli M, Cervetto C, Kitada T and Vallarino M: Expression of PINK1 in the brain, eye and ear of mouse during embryonic development. J Chem Neuroanat. 41:73–85. 2011. View Article : Google Scholar | |
Narendra D, Walker JE and Youle R: Mitochondrial quality control mediated by PINK1 and Parkin: Links to parkinsonism. Cold Spring Harb Perspect Biol. 4:a0113382012. View Article : Google Scholar : PubMed/NCBI | |
Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG and Cheng HC: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet. 15:3251–3262. 2006. View Article : Google Scholar : PubMed/NCBI | |
Okatsu K, Oka T, Iguchi M, Imamura K, Kosako H, Tani N, Kimura M, Go E, Koyano F, Funayama M, et al: PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat Commun. 3:10162012. View Article : Google Scholar : PubMed/NCBI | |
Pridgeon JW, Olzmann JA, Chin LS and Li L: PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5:e1722007. View Article : Google Scholar : PubMed/NCBI | |
Gaki GS and Papavassiliou AG: Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromolecular Med. 16:217–230. 2014. View Article : Google Scholar : PubMed/NCBI | |
Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, et al: The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol. 9:1243–1252. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lenzi P, Marongiu R, Falleni A, Gelmetti V, Busceti CL, Michiorri S, Valente EM and Fornai F: A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death. Arch Ital Biol. 150:194–217. 2012.PubMed/NCBI | |
Chu CT: A pivotal role for PINK1 and autophagy in mitochondrial quality control: Implications for Parkinson disease. Hum Mol Genet. 19:R28–R37. 2010. View Article : Google Scholar : PubMed/NCBI | |
Choi I, Kim J, Jeong HK, Kim B, Jou I, Park SM, Chen L, Kang UJ, Zhuang X and Joe EH: PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and down-regulation of EGFR. Glia. 61:800–812. 2013. View Article : Google Scholar : PubMed/NCBI | |
Lin W and Kang UJ: Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem. 106:464–474. 2008. View Article : Google Scholar : PubMed/NCBI | |
Wei H, Liu L and Chen Q: Selective removal of mitochondria via mitophagy: Distinct pathways for different mitochondrial stresses. Biochim Biophys Acta. 1853:2784–2790. 2015. View Article : Google Scholar : PubMed/NCBI | |
Eiyama A and Okamoto K: PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol. 33:95–101. 2015. View Article : Google Scholar : PubMed/NCBI | |
Dias V, Junn E and Mouradian MM: The role of oxidative stress in Parkinson's disease. J Parkinsons Dis. 3:461–491. 2013.PubMed/NCBI | |
McCoy MK, Kaganovich A, Rudenko IN, Ding J and Cookson MR: Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. Hum Mol Genet. 23:145–156. 2014. View Article : Google Scholar | |
Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R, Nerini-Molteni S, Sale P, Vago R, Arena G, et al: The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ. 17:962–974. 2010. View Article : Google Scholar : PubMed/NCBI | |
Cherra SJ III and Chu CT: Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol. 3:309–323. 2008.PubMed/NCBI | |
Cherra SJ III, Dagda RK and Chu CT: Review: autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol. 36:125–132. 2010. View Article : Google Scholar : PubMed/NCBI | |
Moriwaki Y, Kim YJ, Ido Y, Misawa H, Kawashima K, Endo S and Takahashi R: L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci Res. 61:43–48. 2008. View Article : Google Scholar : PubMed/NCBI | |
Sun F, Kanthasamy A, Anantharam V and Kanthasamy AG: Environmental neurotoxic chemical-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease. Pharmacol Ther. 114:327–344. 2007. View Article : Google Scholar : PubMed/NCBI | |
Meissner C, Lorenz H, Weihofen A, Selkoe DJ and Lemberg MK: The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem. 117:856–867. 2011. View Article : Google Scholar : PubMed/NCBI | |
Matsuda S, Kitagishi Y and Kobayashi M: Function and characteristics of PINK1 in mitochondria. Oxid Med Cell Longev. 2013:6015872013. View Article : Google Scholar : PubMed/NCBI | |
Dagda RK and Chu CT: Mitochondrial quality control: Insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr. 41:473–479. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, Kitada T, Kim JM and Chung J: PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun. 377:975–980. 2008. View Article : Google Scholar : PubMed/NCBI | |
Narendra D, Tanaka A, Suen DF and Youle RJ: Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 183:795–803. 2008. View Article : Google Scholar : PubMed/NCBI | |
Narendra DP and Youle RJ: Targeting mitochondrial dysfunction: Role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal. 14:1929–1938. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S and Youle RJ: PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol. 205:143–153. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M and Muqit MM: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J. 460:127–139. 2014. View Article : Google Scholar : PubMed/NCBI | |
Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T, et al: Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 510:162–166. 2014.PubMed/NCBI | |
Fang EF, Scheibye-Knudsen M, Brace LE, Kassahun H, SenGupta T, Nilsen H, Mitchell JR, Croteau DL and Bohr VA: Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell. 157:882–896. 2014. View Article : Google Scholar : PubMed/NCBI | |
Scheibye-Knudsen M, Fang EF, Croteau DL and Bohr VA: Contribution of defective mitophagy to the neurodegeneration in DNA repair-deficient disorders. Autophagy. 10:1468–1469. 2014. View Article : Google Scholar : PubMed/NCBI | |
Tang BL: Sirt1 and the mitochondria. Mol Cells. 39:87–95. 2016. View Article : Google Scholar : PubMed/NCBI | |
Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS and Fon EA: Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 13:378–385. 2012. View Article : Google Scholar : PubMed/NCBI | |
Das S, Mitrovsky G, Vasanthi HR and Das DK: Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev. 2014:3451052014. View Article : Google Scholar : PubMed/NCBI | |
Mei Y, Zhang Y, Yamamoto K, Xie W, Mak TW and You H: FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc Natl Acad Sci USA. 106:5153–5158. 2009. View Article : Google Scholar : PubMed/NCBI | |
Sengupta A, Molkentin JD, Paik JH, DePinho RA and Yutzey KE: FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem. 286:7468–7478. 2011. View Article : Google Scholar : | |
Requejo-Aguilar R, Lopez-Fabuel I, Jimenez-Blasco D, Fernandez E, Almeida A and Bolaños JP: DJ1 represses glycolysis and cell proliferation by transcriptionally upregulating Pink1. Biochem J. 467:303–310. 2015. View Article : Google Scholar : PubMed/NCBI | |
Sin TK, Yung BY, Yip SP, Chan LW, Wong CS, Tam EW and Siu PM: SIRT1-dependent myoprotective effects of resveratrol on muscle injury induced by compression. Front Physiol. 6:2932015. View Article : Google Scholar : PubMed/NCBI | |
Lin CH, Lin CC, Ting WJ, Pai PY, Kuo CH, Ho TJ, Kuo WW, Chang CH, Huang CY and Lin WT: Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts. Age (Dordr). 36:97052014. View Article : Google Scholar | |
Castillo-Quan JI, Li L, Kinghorn KJ, Ivanov DK, Tain LS, Slack C, Kerr F, Nespital T, Thornton J, Hardy J, et al: Lithium promotes longevity through GSK3/NRF2-dependent hormesis. Cell Rep. 15:638–650. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lewis KN, Wason E, Edrey YH, Kristan DM, Nevo E and Buffenstein R: Regulation of Nrf2 signaling and longevity in naturally long-lived rodents. Proc Natl Acad Sci USA. 112:3722–3727. 2015.PubMed/NCBI | |
Murata H, Takamatsu H, Liu S, Kataoka K, Huh NH and Sakaguchi M: NRF2 regulates PINK1 expression under oxidative stress conditions. PLoS One. 10:e01424382015. View Article : Google Scholar : PubMed/NCBI | |
Huang ST, Ho CS, Lin CM, Fang HW and Peng YX: Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent. Bioorg Med Chem. 16:8619–8626. 2008. View Article : Google Scholar : PubMed/NCBI | |
Amorati R, Valgimigli L, Panzella L, Napolitano A and d'Ischia M: 5-S-lipoylhydroxytyrosol, a multidefense antioxidant featuring a solvent-tunable peroxyl radical-scavenging 3-thio-1,2-dihydroxybenzene motif. J Org Chem. 78:9857–9864. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kenneth NS, Hucks GE Jr, Kocab AJ, McCollom AL and Duckett CS: Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways. Cell Cycle. 13:1006–1014. 2014. View Article : Google Scholar : | |
Deng ZY, Hu MM, Xin YF and Gang C: Resveratrol alleviates vascular inflammatory injury by inhibiting inflammasome activation in rats with hypercholesterolemia and vitamin D2 treatment. Inflamm Res. 64:321–332. 2015. View Article : Google Scholar : PubMed/NCBI | |
Baolin L, Inami Y, Tanaka H, Inagaki N, Iinuma M and Nagai H: Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med. 70:305–309. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY and Sun AY: Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958:439–447. 2002. View Article : Google Scholar : PubMed/NCBI | |
Eid N, Ito Y, Maemura K and Otsuki Y: Elevated autophagic sequestration of mitochondria and lipid droplets in steatotic hepatocytes of chronic ethanol-treated rats: An immunohistochemical and electron microscopic study. J Mol Histol. 44:311–326. 2013. View Article : Google Scholar : PubMed/NCBI | |
Song YM, Lee WK, Lee YH, Kang ES, Cha BS and Lee BW: Metformin restores Parkin-mediated mitophagy, suppressed by cytosolic p53. Int J Mol Sci. 17:E1222016. View Article : Google Scholar : PubMed/NCBI | |
Khang R, Park C and Shin JH: Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice. Neuroscience. 294:182–192. 2015. View Article : Google Scholar : PubMed/NCBI | |
Luo X, Jia R, Yao Q, Xu Y, Luo Z, Luo X and Wang N: Docosahexaenoic acid attenuates adipose tissue angiogenesis and insulin resistance in high fat diet-fed middle-aged mice via a sirt1-dependent mechanism. Mol Nutr Food Res. 60:871–885. 2016. View Article : Google Scholar : PubMed/NCBI | |
Borengasser SJ, Faske J, Kang P, Blackburn ML, Badger TM and Shankar K: In utero exposure to prepregnancy maternal obesity and postweaning high-fat diet impair regulators of mitochondrial dynamics in rat placenta and offspring. Physiol Genomics. 46:841–850. 2014. View Article : Google Scholar : PubMed/NCBI | |
Ono K and Yamada M: Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: Implications for Lewy body diseases. Neurobiol Dis. 25:446–454. 2007. View Article : Google Scholar | |
Casarejos MJ, Menéndez J, Solano RM, Rodríguez-Navarro JA, García de Yébenes J and Mena MA: Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem. 97:934–946. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sonia Angeline M, Chaterjee P, Anand K, Ambasta RK and Kumar P: Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat. Neuroscience. 220:291–301. 2012. View Article : Google Scholar : PubMed/NCBI | |
Zhang YY, Huang J, Yang M, Gu LJ, Ji JY, Wang LJ and Yuan WJ: Effect of a low-protein diet supplemented with keto-acids on autophagy and inflammation in 5/6 nephrectomized rats. Biosci Rep. 35:e002632015. View Article : Google Scholar : PubMed/NCBI | |
Koh H and Chung J: PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity. Mol Cells. 34:7–13. 2012. View Article : Google Scholar : PubMed/NCBI |